Suppr超能文献

在印度建立抗菌药物耐药性监测与研究网络:迄今的历程。

Establishing Antimicrobial Resistance Surveillance & Research Network in India: Journey so far.

机构信息

Division of Epidemiology & Communicable Diseases, Indian Council of Medical Research, New Delhi, India.

Department of Clinical Microbiology, Christian Medical College, Vellore, India.

出版信息

Indian J Med Res. 2019 Feb;149(2):164-179. doi: 10.4103/ijmr.IJMR_226_18.

Abstract

The Indian Council of Medical Research, in 2013, initiated the Antimicrobial Resistance Surveillance & Research Network (AMRSN) to enable compilation of data on six pathogenic groups on antimicrobial resistance from the country. The overarching aim of this network was to understand the extent and pattern of antimicrobial resistance (AMR) and use this evidence to guide strategies to control the spread of AMR. This article describes the conception and implementation of this AMR surveillance network for India. Also described are the challenges, limitations and benefits of this approach. Data from the Network have shown increasing resistance in Gram-negative bacteria in the hospitals that are part of this network. Combined resistance to third-generation cephalosporins and fluoroquinolones and increasing carbapenem resistance are worrisome, as it has an important bearing on the patients' outcome and thus needs to be addressed urgently. Data generated through this Network have been used to develop treatment guidelines, which will be supportive in harmonizing treatment practices across the tertiary level healthcare institutions in the country. While, the major benefit of having a surveillance system is the collection of real-time accurate data on AMR including the mechanisms of resistance, representativeness to community, sustaining the current effort and expanding the current activities to next levels of healthcare settings are the major challenges. The data emanating from the network besides providing evidence, expose several gaps and lacunae in the ecosystem and highlight opportunities for action by multiple stakeholders.

摘要

印度医学研究理事会于 2013 年启动了抗菌药物耐药性监测和研究网络(AMRSN),以汇集该国六种病原体组对抗菌药物耐药性的数据。该网络的总体目标是了解抗菌药物耐药性(AMR)的程度和模式,并利用这些证据来指导控制 AMR 传播的策略。本文描述了该 AMR 监测网络在印度的构想和实施情况。还描述了这种方法的挑战、限制和益处。该网络的数据显示,参与该网络的医院中革兰氏阴性菌的耐药性呈上升趋势。第三代头孢菌素和氟喹诺酮类药物的联合耐药以及碳青霉烯类耐药性的增加令人担忧,因为这对患者的预后有重要影响,因此需要紧急解决。通过该网络生成的数据已被用于制定治疗指南,这将有助于协调全国三级医疗机构的治疗实践。虽然拥有监测系统的主要好处是实时收集有关 AMR 的准确数据,包括耐药机制,但代表性问题、能否维持当前的努力以及将当前活动扩展到下一级别的医疗保健机构,这些都是主要挑战。网络产生的数据除了提供证据外,还暴露出生态系统中的若干差距和缺陷,并突出了多个利益相关者采取行动的机会。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9a8/6563732/a1b11bc67312/IJMR-149-164-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验